Insilico Medicine and Eli Lilly to anchor 13th Aging Research & Drug Discovery (ARDD) meeting at the David Rubenstein Treehouse at Harvard University - EurekAlert!
Insilico Medicine releases positive profit alert for the first half of 2026 - EurekAlert!
Pharma.AI Q2 2026 Summer Webinar: A Deep Dive into Insilico Medicine’s Latest Platform Upgrades - EurekAlert!
Insilico Medicine shines at International Executive Summit, sharing the journey from tech innovation to clinical validation in AI drug discovery - EurekAlert!
Insilico Medicine announces collaboration with Takeda to advance strategic AI drug discovery - EurekAlert!
Insilico Medicine caps monumental week at BIO 2026: Secures landmark $2.5B partnership and dominates thought leadership - EurekAlert!
Insilico Medicine caps monumental week at BIO 2026: Secures landmark $2.5B partnership and dominates thought leadership - EurekAlert!
Weekly Conferences | From San Diego to Shanghai: Insilico Medicine showcases new advances in AI-driven drug discovery - EurekAlert!
Bridging technology and clinic: Insilico Medicine at Morgan Stanley China Biopharma Symposium 2026 - EurekAlert!
Insilico Medicine to showcase AI-driven innovation at BIO 2026 International Convention - EurekAlert!
Advancing drug discovery from automation to autonomy: Insilico Medicine announces LabClaw The Intelligent System - EurekAlert!
Generative AI leap: Insilico Medicine nominates first preclinical candidate in the UAE - EurekAlert!
Insilico Medicine announces industry’s first longevity board to accelerate AI-driven aging research for drug discovery - EurekAlert!
Insilico Medicine advances AI-driven target discovery with validated TargetPro–TargetBench framework - EurekAlert!
Insilico Medicine expands MMAI Gym with benchmark leaderboard portals for scientific research and drug discovery - EurekAlert!
Insilico Medicine and Tenacia Biotechnology expand AI-driven CNS collaboration with deal Value up to US $94.75 million - EurekAlert!
Insilico Medicine named to Fast Company’s annual list of the world’s most innovative companies of 2026 - EurekAlert!
Insilico Medicine launches PandaClaw: Empowering biologists with agentic AI for therapeutic discovery - EurekAlert!
Insilico Medicine announces inclusion in Hang Seng Index and Stock Connect program - EurekAlert!
ACS Central Science | Researchers from Insilico Medicine and Lilly publish foundational vision for fully autonomous “Prompt-to-Drug” pharmaceutical R&D - EurekAlert!
